Evidence map›Paper›PMID 36831459›Full record

ArticleCancers2023

Explainable AI for Estimating Pathogenicity of Genetic Variants Using Large-Scale Knowledge Graphs.

Shuya Abe, Shinichiro Tago, Kazuaki Yokoyama, Miho Ogawa, Tomomi Takei, Seiya Imoto, Masaru Fuji

Abstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Toward Advanced Quantitative Prediction of Missense Variant Effects.International journal of molecular sciences · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shuya AbeArtificial Intelligence Laboratory, Fujitsu Research, Fujitsu Ltd., Kawasaki 211-8588, Japan.
Shinichiro TagoArtificial Intelligence Laboratory, Fujitsu Research, Fujitsu Ltd., Kawasaki 211-8588, Japan.ORCID 0000-0003-3071-5165
Kazuaki YokoyamaDepartment of Cell Processing and Transfusion, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.ORCID 0000-0002-2556-3833
Miho OgawaDepartment of Cell Processing and Transfusion, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Tomomi TakeiDepartment of Cell Processing and Transfusion, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Seiya ImotoDivision of Health Medical Intelligence, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Masaru FujiArtificial Intelligence Laboratory, Fujitsu Research, Fujitsu Ltd., Kawasaki 211-8588, Japan.

Funding

Japan Agency for Medical Research and Development JP20KK0205013
6 · The paper itself

Abstract

backgroundTo treat diseases caused by genetic variants, it is necessary to identify disease-causing variants in patients. However, since there are a large number of disease-causing variants, the application of AI is required. We propose AI to solve this problem and report the results of its application in identifying disease-causing variants.

methodsTo assist physicians in their task of identifying disease-causing variants, we propose an explainable AI (XAI) that combines high estimation accuracy with explainability using a knowledge graph. We integrated databases for genomic medicine and constructed a large knowledge graph that was used to achieve the XAI.

resultsWe compared our XAI with random forests and decision trees.

conclusionWe propose an XAI that uses knowledge graphs for explanation. The proposed method achieves high estimation performance and explainability. This will support the promotion of genomic medicine.

Indexed as

cancer genomic medicinedeep learningexplainable AIknowledge graphprecision medicine

Identifiers

PMID36831459
PMCPMC9953952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.